![](https://cdn.sanity.io/images/0vv8moc6/dermatologytimes/7346d1a25d5342ac1dca104c3343e59efbefe796-3500x2333.jpg?fit=crop&auto=format)
The FDA Approves Deuruxolitinib for Severe Alopecia in Adults
The US Food and Drug Administration (FDA) has approved deuruxolitinib (Leqselvi; Sun Pharma), an oral Janus Kinase (JAK) inhibitor, for the treatment of severe alopecia areata in adults. Deuruxolitinib operates by selectively inhibiting JAK1 and JAK2, …